MIT Technology Review @techreview A media company making technology a greater force for good. Get our journalism: go.technologyreview.com/newsletters May. 13, 2019 1 min read

How biotech went from “no way” to payday in the cannabis business  https://trib.al/jrJYXFY 

Genetic engineers want to use baker's yeast to make bio-pot, for fun and health.  https://trib.al/jrJYXFY 

Synthetic-biology company Amyris believes it can genetically engineer organisms to manufacture cannabinoids, the active molecules in marijuana, more cheaply than by growing plants.  https://trib.al/jrJYXFY 

If it works, cannabinoids could end up everywhere, in new forms, and reaching new people.
.
Despite some moral qualms, the biotech industry is increasingly embracing the legal cannabis sector, which is growing rapidly on the back of spreading legalization in the US and beyond.

But their venture could backfire if they help create a public health menace.  https://www.technologyreview.com/s/613511/how-biotech-went-from-no-way-to-payday-in-the-cannabis-business/?utm_campaign=site_visitor.unpaid.engagement&utm_source=twitter&utm_medium=tr_social 


You can follow @techreview.



Bookmark

____
Tip: mention @threader_app on a Twitter thread with the keyword “compile” to get a link to it.

Enjoy Threader? Sign up.

Threader is an independent project created by only two developers. The site gets 500,000+ visits a month and our iOS Twitter client was featured as an App of the Day by Apple. Running this space is expensive and time consuming. If you find Threader useful, please consider supporting us to make it a sustainable project.